Relypsa Inc
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$29.3M | −$15.7M | −$70.9M |
| Net income | −$29.7M | −$16.1M | −$73.8M |
| Total assets | $278.3M | $151.8M | $106.0M |
| Total liabilities | $93.5M | $33.4M | $31.2M |
| Equity | $184.9M | $118.5M | $74.8M |
| EPS (diluted) | — | — | — |
| Shares out. | 41.3M | 35.0M | 29.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- —
- Net margin
- —
- Return on equity
- −16.0%
- Return on assets
- −10.7%
- Return on capital (ROCE)
- −14.0%
- Liabilities / assets
- 33.6%
- Debt / equity
- 0.51×
- Book value / share
- $4.48
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- 0.11distress
- Accruals / assets
- 28.9%high accruals
- Piotroski F-Score
- 0/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 1 good- Altman Z″ in the distress zone
- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Torley HelenDirector | Sep 1, 2016 | U | 1,237 | $32.00 |
| Spiegelman Daniel KDirector | Sep 1, 2016 | U | 1,237 | $32.00 |
| Schuetz Thomas J.Director | Sep 1, 2016 | U | 33,962 | $32.00 |
| Mcgirr David W JDirector | Sep 1, 2016 | U | 2,729 | $32.00 |
| Hillan Kenneth J.Director | Sep 1, 2016 | U | 1,237 | $32.00 |
| Hastings Paul JDirector | Sep 1, 2016 | U | 2,495 | $32.00 |
| Butler John P.Director | Sep 1, 2016 | U | 2,849 | $32.00 |
| Stahl WilhelmOfficer — SVP, Chief Technology Officer | Sep 1, 2016 | Grant | 2,917 | $0.00 |
| Orwin John AOfficer — President & CEO | Sep 1, 2016 | Grant | 11,250 | $0.00 |
| Montgomery MonteOfficer — Chief Accounting Officer | Sep 1, 2016 | Grant | 2,200 | $0.00 |
| Krasnow Ronald A.Officer — See Remarks | Sep 1, 2016 | Grant | 2,917 | $0.00 |
| Harrison Stephen DOfficer — SVP & Chief Scientific Officer | Sep 1, 2016 | Grant | 4,167 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 1, 2016
- Entered a material agreement · Regulation FD disclosureJul 21, 2016
- Other material eventJul 11, 2016
- Shareholder voteJun 27, 2016
- Other material eventJun 15, 2016
- Other material eventMay 16, 2016
- Results of operationsMay 4, 2016
- Entered a material agreement · New financial obligation · Unregistered equity saleMay 3, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.